Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

MOREPEN LABORATORIES LTD. - 500288 - Board Meeting Intimation for Intimation Of Board Meeting

 MOREPEN LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2022 ,inter alia, to consider and approve (1) Standalone and consolidated un-audited financial results of the company for the quarter ended December 31, 2021; and (2) Variation/alteration of preference shareholders' rights, by converting said unlisted preference shares into Compulsorily Convertible Preference Shares and issuance of Equity Shares arising on conversion thereof, subject to the approval of preference shareholders, equity shareholders and such other regulatory, statutory authority(ies), as may be required.
20-01-2022
Bigul

MOREPEN LABORATORIES LTD. - 500288 - Statement Of Investor Complaints For The Quarter Ended December 2021

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0220 Name of the Signatory :- Vipul Kumar SrivastavaDesignation :- Company Secretary and Compliance Officer
17-01-2022
Bigul

MOREPEN LABORATORIES LTD. - 500288 - Quarterly Disclosures By Listed Entities Of Defaults On Payment Of Interest/ Repayment Of Principal Amount On Loans From Banks / Financial Institutions And Unlisted Debt Securities

 Quarterly Disclosures by listed entities of defaults on payment of interest/ repayment of principal amount on loans from banks / financial institutions and unlisted debt securities
07-01-2022
Bigul

MOREPEN LABORATORIES LTD. - 500288 - Closure of Trading Window

 Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended, and in accordance with the Code of Conduct to Regulate, Monitor and Report of Trading by Insiders for trading in Company''s Shares/ Securities, the Trading Window will remain closed with effect from January 01, 2022 for the purpose of consideration and approval of unaudited financial results for the quarter ended December 31, 2021. During the aforesaid closed trading window period, the Designated Persons shall not trade in Company''s shares/ securities. The Trading Window shall remain closed till 48 hours after the announcement of the said financial results, when the information becomes generally available.
31-12-2021
Bigul

MOREPEN LABORATORIES LTD. - 500288 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to the Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, please find attached herewith letter dated 22nd December, 2021, received from Registrar and Share Transfer Agent (viz., Mas Services Limited) of the company regarding loss of share certificate of the company.
23-12-2021
Bigul

MOREPEN LABORATORIES LTD. - 500288 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to the Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, please find attached herewith letter dated 20th December, 2021, received from Registrar and Share Transfer Agent (viz., Mas Services Limited) of the company, comprising information related to issue of duplicate share certificates of the company.
20-12-2021

Morepen Laboratories gets USFDA nod to market generic anti-allergy drug

 Morepen's product is the generic version of Sanofi Aventis' anti- allergy drug.
03-12-2021
Bigul

MOREPEN LABORATORIES LTD. - 500288 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

 Please find enclosed the press release with the title - 'Morepen gets US FDA Approval for Fexofinadine (Allegra) Expected to start export in Q4'FY22'
03-12-2021
Bigul

Morepen Laboratories Ltd - 500288 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to the Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, please find attached herewith letter dated 26th November, 2021, received from Registrar and Share Transfer Agent (viz., Mas Services Limited) of the company regarding loss of share certificate of the company.
26-11-2021
Bigul

MOREPEN LABORATORIES LTD. - 500288 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

 Please find attached transcript of 'Analyst/ Investor Conference Call' organised on Thursday, 11th November, 2021 at 04:00 P.M. (IST), subsequent to the declaration of unaudited standalone and consolidated financial results for the quarter and half year ended 30th September, 2021.
18-11-2021
Next Page
Close

Let's Open Free Demat Account